ArticleRadiation oncology (London, England)2025

Efficacy and safety of concurrent programmed cell death protein 1 inhibitor and definitive radiotherapy with immunonutrition support in esophageal squamous cell cancer: a phase II multicenter clinical trial.

Yupei Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.